Literature DB >> 7438118

Toxicity and pharmacology of bolus vindesine injection and prolonged vindesine infusion.

K Hande, J Gay, J Gober, F A Greco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7438118     DOI： 10.1016/s0305-7372(80)80004-1

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  6 in total

1.  Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres.

Authors:  J Marinina; A Shenderova; S R Mallery; S P Schwendeman
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

2.  Pharmacokinetics of vindesine bolus and infusion.

Authors:  D V Jackson; V S Sethi; T R Long; H B Muss; C L Spurr
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine.

Authors:  J A Young; S B Howell; M R Green
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 4.  Preclinical and clinical pharmacology of vinca alkaloids.

Authors:  X J Zhou; R Rahmani
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

6.  Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.

Authors:  R Pazdur; A H Rossof; G Chandra; P D Bonomi; R E Slayton; J Wolter
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.